Nanobiotix has presented complete outcomes from the dose escalation and dose expansion phases of the Phase I trial of ...

Janux Therapeutics has commenced Phase Ib expansion trials with JANX007 in the first-in-human ENGAGER-PSMA-01 clinical trial.

Research and development (R&D) investment in the Swiss biotech sector grew in 2024, despite ongoing global funding struggles.

Europe meeting, experts discussed the challenges and strategies of small and mid-sized biopharma companies surrounding ...

The stages of clinical trial transition include strategic initiation and planning to establish action points within the ...